0
Upcoming Allied Market Research
2023
Amifampridine Market

Amifampridine Market

by Type (Generic, Patent), by Application (Myasthenia Gravis, Potassium Channel Blocker) and by End User (Hospitals and Clinics, Specialty Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A12337
Pages: NA
Jul 2023 | 1662 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Amifampridine Market

Request Now !

Amifampridine Market Overview: 2030

Amifamprdine is used as a drug for treating a number of rare muscle diseases. The free base form of amifampridine is used to treat Lambert–Eaton myasthenic syndrome (LEMS) and congenital myasthenic syndromes. It was discovered in Scotland in the 1970s, and its use in LEMS was first shown in the 1980s. Amifampridine, a quaternary ammonium compound, can help block the presynaptic potassium channels. Thus, the drug helps prolong the action potential and aids in increasing presynaptic calcium concentration. Amifampridine is ideally given in the form of oral tablets three or four times a day

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.

However, with COVID-19, the supply chain of raw materials required to manufacture amifampridine has been disrupted in many countries. In addition, the market growth of pharmaceuticals is declining, as the manufacturers of drugs have slowed down their production due to the pandemic. With reduction in production activities, shortage of amifampridine has been witnessed in in many regions. This, in turn, is expected to have a significant impact on the amifampridine market.

Top Impacting Factors

Rise in prevalence of muscle-specific kinase myasthenia gravis is positively influencing the amifampridine market. This is attributed to the fact that amifampridine can be used to lessen symptoms of loss of muscle movement and muscle weakness associated with muscle-specific kinase myasthenia gravis.

Increase in healthcare spending by governments all across the world is enabling the manufacturers of amifampridine to penetrate deeper into the market. This factor is therefore positively influencing the market growth.

The demand for better drugs that help control the symptoms of rare muscle diseases such as Lambert–Eaton myasthenic syndrome (LEMS) and congenital myasthenic syndromes has fueled the growth of the market.

However, amifampridine can affect the voltage-gated channels of the heart which is why it is contraindicated in people who have the long QT syndrome. Hence, this factor can impede the growth of the amifampridine market.

Key Market Trends

Many key players of the amifampridine market are focusing on assessing challenges that could influence the dominance of amifampridine. With this, they are finding opportunities to serve a large customer base.

North America holds a major share of the amifampridine market, owing to availability of sophisticated healthcare infrastructure and high purchasing power of citizens. With high purchasing power, the people of this region can easily seek healthcare services and afford the cost of pharmaceuticals.

Europe is one of the leading players in the market, attributable to favorable healthcare reimbursement policies for citizens.

In addition, Asia-Pacific is anticipated to show a high growth rate in the amifampridine market due to presence of high population base and rise in cases of muscle-specific kinase myasthenia gravis.

Key Benefits of the Report

  • This study presents the analytical depiction of the amifampridine industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the amifampridine market share.
  • The current market is quantitatively analyzed to highlight the amifampridine market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Amifampridine Report

  • Which are the leading players active in the amifampridine market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the amifampridine market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps in the market?
  • What are the impacts of COVID-19 on the industry?
  • What is amifampridine?
  • What are the current and predicted trends of the market?

Amifampridine Market Report Highlights

Aspects Details
By Type
  • Generic
  • Patent
By Application
  • Myasthenia Gravis
  • Potassium Channel Blocker
By End User
  • Hospitals and Clinics
  • Specialty Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Glenmark Pharmaceuticals Ltd., Jacobus Pharmaceutical, Inc., BLD Pharmatech Ltd., Biosynth AG, Merck and Co., Inc., Unichem Laboratories, Innovapharm Ltd.,, BioMarin Pharmaceutical, Inc., Norris Pharm Technology Co. Ltd., Wockhardt Ltd.
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Amifampridine Market

Start reading.
This Report and over 53,743+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers